- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Bone Mineral Density (BMD)
- Meeting Date: November 2012
- Public Summary Document (PSD) November 2012 PBAC Meeting - PDF
Zoledronic acid – November 2012
Zoledronic Acid, solution for I.V. infusion, 5 mg (as monohydrate) in 100 mL, Aclasta®
Last updated
8 November 2023